Tech Company Financing Transactions
Biolexis Funding Round
Biolexis, based in American Fork, secured $10 million from Clarke Capital Partners.
Transaction Overview
Company Name
Announced On
11/29/2023
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Clarke Capital Partners (Lead Investor)
Proceeds Purpose
The new funding round will accelerate the company's drug discovery pipeline. Funds for Advance Metabolic Drug Development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
858 S Auto Mall Dr. #102
American Fork, UT 84003
USA
American Fork, UT 84003
USA
Phone
Website
Email Address
Overview
Advanced technology and science to improve every life. Our mission is to map the interactions of chemicals and proteins to discover new products to benefit humanity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Bearss
Chief Financial Officer
David Taylor
Browse more venture capital transactions:
Prev: 11/29/2023: Letterhead venture capital transaction
Next: 11/29/2023: Vesper Tool venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs